by Alysa | Mar 29, 2016 | UNITAID News
GENEVA, 24 March – UNITAID today launched its latest call for funding proposals, focused on scaling up better tuberculosis (TB) treatment for children. Innovative approaches are being sought to ease adoption of new TB drugs and make them more accessible to...
by Alysa | Jan 29, 2016 | UNITAID News
Geneva, 1 February 2016: UNITAID and IVCC (Innovative Vector Control Consortium) today announced an initiative to expand the use of new anti-malarial insecticides to maintain the important role of mosquito control in combating malaria. The US $65.1 million initiative,...
by Alysa | Jan 20, 2016 | UNITAID News
Geneva, 19 January 2016 – UNITAID welcomes agreements to manufacture a key Hepatitis C medicine and make it available in many low- and middle-income countries. The Medicines Patent Pool (MPP), which is fully funded by UNITAID, signed licenses for the generic...
by Alysa | Dec 18, 2015 | UNITAID News
Geneva, 18 December 2015 — The Medicines Patent Pool (MPP) today announced a new licensing agreement with AbbVie, a global biopharmaceutical company, that seeks to address future demands for HIV treatment Lopinavir/Ritonavir (LPV/r) in South Africa and across Africa....
by Alysa | Nov 27, 2015 | UNITAID News
UNITAID today released its 2015 HIV/AIDS Diagnostics Technology Landscape that summarizes the latest products and technologies to detect, stage and monitor HIV infection. The Landscape covers technologies including instruments for laboratories, multi-purpose platforms...
Recent Comments